Tianda Pharmaceuticals Limited (0455.HK) HKSE

0.09

+0.007(+8.14%)

Updated at June 01 01:20PM

Currency In HKD

Valuation

Market Cap277.36M
Enterprise Value345.21M
P/E Ratio-2.82
PEG Ratio0.09
Price/Sales Ratio0.56
Price/Book Ratio0.44
Enterprise/Revenue0.74
Enterprise/EBITDA-7.96

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.2
Operating Margin-0.14

Management Effectiveness

Return On Assets-0.09
Return On Equity-0.15

Income Statement

Revenue322.95M
Revenue/Share0.17
Gross Profit133.31M
EBITDA-24.41M
Net Income-70M
Diluted EPS-0.03

Balance Sheet

Total Cash64.81M
Total Cash/Share0.03
Total Debt132.66M
Total Debt/Equity0.29
Current Ratio0.83
Book Value Per Share0.21

Price History

52-Week Change-34.04
52-Week High0.22
52-Week Low0.08
Moving Average 50 Days0.09
Moving Average 200 Days0.12

Statistics

Average Volume23,333
Shares Outstanding2.15B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.04
Last Split Factor1447:1000
Last Split DateJuly 08, 2010